Ticker
IOVACompany Name
IOVANCE BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 907.44M | $ -389.92M | -42.97% |
3/31/2025 | $ 966.74M | $ -375.36M | -38.83% |
12/31/2024 | $ 910.43M | $ -372.18M | -40.88% |
9/30/2024 | $ 991.12M | $ -410M | -41.37% |
6/30/2024 | $ 964.32M | $ -440.22M | -45.65% |
3/31/2024 | $ 869.83M | $ -449.64M | -51.69% |
12/31/2023 | $ 780.35M | $ -444.04M | -56.9% |
9/30/2023 | $ 852.32M | $ -432.98M | -50.8% |
6/30/2023 | $ 757.29M | $ -418.83M | -55.31% |
3/31/2023 | $ 824.77M | $ -411.66M | -49.91% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -254.75M ] / Assets [ $ 782.29M ]
(=) ROA [ -32.56% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.51% |
max | 33.98% |
average | 0.07% |
median | 1.52% |
std | 10.68% |